Literature DB >> 19589910

Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2.

S I Chisalita1, G S Johansson, E Liefvendahl, K Bäck, H J Arnqvist.   

Abstract

Whether insulin, at physiological concentrations, has direct effects on vascular smooth muscle cells (VSMCs) remains controversial. Our aim was to characterize the mechanism for insulin resistance in VSMCs. For comparison, the effects of IGF1 and IGF2 were also studied. Cultured human aortic smooth muscle cells (HASMC) were used. Receptor mRNA was analyzed by quantitative reverse transcription PCR and receptor protein by ELISA and western blot. Biological effects were studied by thymidine incorporation and glucose accumulation. In HASMC, both mRNA and protein expression of IGF1 receptors (IGF1R) were fivefold higher compared to insulin receptor (IR). IR isoform A mRNA was 13-fold more expressed than IR isoform B. IR and IGF1R co-precipitated, indicating the presence of hybrid IR/IGF1R. Phosphorylation of the IGF1R beta-subunit was obtained by IGF1 10(-9)-10(-8) mol/l and IGF2 10(-8) mol/l. IR beta-subunit was phosphorylated by IGF1 10(-8) mol/l but not by insulin. IGF1 stimulated IR substrate-1 and AKT at 10(-8) mol/l and extracellular signal-regulated kinases 1 and 2 at 10(-9)-10(-8) mol/l respectively. IGF1 and 2 at a concentration of 10(-8)-10(-7) mol/l significantly stimulated (3)H-thymidine incorporation, whereas insulin did not. (14)C-Glucose accumulation was stimulated by IGF1 or IGF2 10(-8)-10(-7) mol/l, and also by insulin 10(-7) mol/l. Our results suggest that IGF1R and hybrid IR/IGF1R are activated by physiological concentrations of IGF1 and 2 in HASMC and this propagates downstream signaling and biological effects, while insulin has no effect on its receptor or downstream signaling probably due to a preponderance of IGF1R and incorporation of IR into hybrid IR/IGF1R.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19589910     DOI: 10.1677/JME-09-0021

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  21 in total

1.  Insulin-like growth factor-1 induces phosphorylation of PI3K-Akt/PKB to potentiate proliferation of smooth muscle cells in human saphenous vein.

Authors:  Guanghong Jia; Amit K Mitra; Deepak M Gangahar; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2010-05-13       Impact factor: 3.362

2.  Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling.

Authors:  L Sciacca; M F Cassarino; M Genua; G Pandini; R Le Moli; S Squatrito; R Vigneri
Journal:  Diabetologia       Date:  2010-04-28       Impact factor: 10.122

Review 3.  The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances.

Authors:  Zoltan Ungvari; Anna Csiszar
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-26       Impact factor: 6.053

4.  IGF-I stimulates cooperative interaction between the IGF-I receptor and CSK homologous kinase that regulates SHPS-1 phosphorylation in vascular smooth muscle cells.

Authors:  Yashwanth Radhakrishnan; Xinchun Shen; Laura A Maile; Gang Xi; David R Clemmons
Journal:  Mol Endocrinol       Date:  2011-07-28

Review 5.  Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy.

Authors:  Yu Zhang; Xinghui Sun; Basak Icli; Mark W Feinberg
Journal:  Endocr Rev       Date:  2017-04-01       Impact factor: 19.871

6.  Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway.

Authors:  Yusuke Higashi; Kevin Holder; Patrice Delafontaine
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

7.  Insulin-like growth factor-II regulates maternal hemodynamic adaptation to pregnancy in rats.

Authors:  Tim Van Mieghem; Rita van Bree; Erik Van Herck; Jan Deprest; Johan Verhaeghe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-09-23       Impact factor: 3.619

8.  IGF-1 deficiency in a critical period early in life influences the vascular aging phenotype in mice by altering miRNA-mediated post-transcriptional gene regulation: implications for the developmental origins of health and disease hypothesis.

Authors:  Stefano Tarantini; Cory B Giles; Jonathan D Wren; Nicole M Ashpole; M Noa Valcarcel-Ares; Jeanne Y Wei; William E Sonntag; Zoltan Ungvari; Anna Csiszar
Journal:  Age (Dordr)       Date:  2016-08-26

9.  Role of UDP-N-acetylglucosamine (GlcNAc) and O-GlcNAcylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis.

Authors:  Davide Vigetti; Sara Deleonibus; Paola Moretto; Eugenia Karousou; Manuela Viola; Barbara Bartolini; Vincent C Hascall; Markku Tammi; Giancarlo De Luca; Alberto Passi
Journal:  J Biol Chem       Date:  2012-08-10       Impact factor: 5.157

Review 10.  Growth factor therapy for cardiac repair: an overview of recent advances and future directions.

Authors:  Samuel J White; James J H Chong
Journal:  Biophys Rev       Date:  2020-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.